<DOC>
	<DOCNO>NCT01585987</DOCNO>
	<brief_summary>The purpose study compare efficacy Ipilimumab standard care sequential maintenance treatment immediately first-line chemotherapy treatment unresectable metastatic gastric gastro-esophageal cancer .</brief_summary>
	<brief_title>An Efficacy Study Gastric Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard Care Immediately Following First Line Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com . Key Histologically confirm , unresectable locally advanced metastatic adenocarcinoma gastric gastroesophageal junction Received firstline chemotherapy use fluoropyrimidine platinum combination without disease progression Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Measurable disease modify WHO criteria ( unless complete response previous chemotherapy ) Key Known Human Epidermal growth factor Receptor2 ( HER2 ) positive status Radiological evidence brain metastasis History severe autoimmune immune mediate disease require prolonged immunosuppressive treatment Inadequate hematologic , renal hepatic function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>